Mwt. LogP HBD HBA PSA RB CSP3
429.0 6.0 0 4 60.0 6 0.81
SYNONYMS
ZINC ID(s)
Availability
Present in 42 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT01899846 2013-07-01 Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood Phase 1 Completed
NCT01317225 2011-06-01 Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With Progesterone Phase 3 Recruiting
NCT00809939 2010-12-01 17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm Labor Phase 3 Active, Not Recruiting
NCT01050647 2010-02-01 Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial. Phase 1/Phase 2 Active, Not Recruiting
NCT01004029 2009-10-01 Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery Phase 3 Recruiting
NCT00439374 2007-04-01 RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix Phase 3 Terminated
NCT00141908 2006-10-01 Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate Phase 2 Completed
NCT00331695 2006-06-01 Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery Phase 4 Completed
NCT00135902 2005-02-01 Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies Phase 3 Completed
NCT00163020 2004-11-01 17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies Phase 2/Phase 3 Completed
NCT00099164 2004-04-01 Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS) Phase 3 Completed

(Browse) Purchasable Analogs in ZINC

Usage Over Time

Comments